Clinical trial Recruiting at 1 site Interventional Ages 18 to 60 Women only

Deep versus moderate muscle relaxation during hysterectomy

Official title: The Effect of Deep Versus Moderate Neuromuscular Blocking on Patients Undergoing Open Hysterectomy

Run by Menoufia University · NCT07485517 · Data updated 2026-11-12

This study will test whether using deep versus moderate muscle relaxation during elective hysterectomy changes surgical conditions, opioid requirements, and blood inflammation markers for women having the operation.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexWomen only
Enrollment88 (estimated)
SponsorMenoufia University
Academic / other
Locations1 site (Menoufia, Eg.mn)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 30, 2026
Registry record updatedAugust 13, 2026
Trial IDNCT07485517 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women scheduled for elective hysterectomy who are ASA I–II with BMI <35 and without neuromuscular, autoimmune, or uncontrolled medical conditions are the intended participants.

Probably not a fit

Patients with neuromuscular disorders, severe anemia, autoimmune disease, or on immunosuppressant therapy are excluded and would not be expected to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Women scheduled for elective hysterectomy at a single center will receive either deep or moderate neuromuscular blockade during their operation, and perioperative management will follow standard protocols. Investigators will compare changes in serum inflammatory cytokines from preoperative baseline and measure total intraoperative fentanyl and postoperative morphine use. Secondary outcomes include postoperative pain scores and surgeons' subjective ratings of the surgical field. Eligibility is limited to ASA I–II patients with BMI under 35, excluding those with neuromuscular disorders, severe anemia, autoimmune disease, or on immunosuppressants.

Why it matters

Potential benefit: If successful, using deeper neuromuscular blockade could improve surgical conditions, reduce opioid consumption, and lower postoperative inflammatory markers after hysterectomy.

How similar studies have gone: Prior work in laparoscopic surgery has shown that deep neuromuscular blockade can improve operating conditions and sometimes reduce opioid needs, but its specific effects on inflammatory cytokines in hysterectomy are less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women who will be admitted to undergo elective hysterectomy

  ,-ASA grade I or II,
* Body mass index (BMI) of \<35 kg/m2

Exclusion Criteria:

hemoglobin concentration of ≤7 gm%,

* the presence of neuromuscular disorders
* uncontrolled medical diseases
* autoimmune diseases, maintenance on immunosuppressant therapy for any indication
* refusal to sign the written consent

Where it's running

  • Faculty of Medicine Menoufia University
    Menoufia, Eg.mn, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.